Moderna Stock Loses Steam. Hantavirus Trade Fizzles as Officials Dismiss Pandemic Risk.
AI Summary
Moderna's stock has declined recently, coupled with the Hantavirus trade losing momentum as officials downplay risks associated with a pandemic outbreak. This suggests a shift in public and market focus post-COVID-19.